President Biden’s plan to spend more than $7 billion on new anti-viral pills to treat Covid as a key tool in the fight against the pandemic could be complicated by a testing crunch.
than Merck's in preventing hospitalization in high-risk groups— 89 percent compared to 30 percent.
On Thursday, the National Institutes of Health's Covid-19 Treatment Guidelines Panel released interim"Logistical or supply constraints may make it impossible to offer available outpatient therapies to all eligible patients," the panel said in a statement. When there is limited availability, the panel said,"patients at highest risk of clinical progression should be prioritized to receive these therapies.
That could help cut down on long lines that have been forming at many testing centers but won’t address long waits for results as labs become inundated with requests. Commercial labs, which have been processing the majority of the country’s Covid tests, are starting to see delays given the surge in demand in certain regions, like New York and New Jersey.
But public health experts warn that could be too little, too late, and say the administration should have done more to prepare for a surge like the one the U.S is experiencing now due to the"The White House has been too often in reaction mode, not being proactive," said Dr. Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine in Houston, speaking on MSNBC this week.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Biden says 'nothing's been good enough' as Covid hotspots see testing shortagesPresident Biden acknowledged his administration has struggled to meet the nation's demand for Covid-19 tests, but he defended the federal response to a surge in cases — driven largely by the Omicron variant.
Weiterlesen »
President Biden to ABC's David Muir on at-home COVID testing: 'Nothing's been good enough'
Weiterlesen »
'Those rooms are full of tears' MI doctor shares realities of caring for COVID patientsAfter nearly two years of the COVID-19 pandemic, hospitals and doctors face immense pressure due to the surging Omicron variant. Dr. Shelley Schmidt of Spectrum Health talks about the harsh realities of caring for COVID patients and the best ways to communicate with those who are still unvaccinated.
Weiterlesen »
U.K. reports 132 Omicron patients admitted to hospitals, 14 deaths from COVID variantScientists said any decrease in Omicron infection severity needs to be considered against the speed of infection of Omicron versus Delta.
Weiterlesen »
Beleaguered hospitals warn patients, push back treatments amid Covid surgeAfter two weeks apart in late September, Sherry Cohen was eager to see her mother, Sandy, who was in quarantine at an assisted living facility at the time.
Weiterlesen »
Long Covid patients are 'terrified' of omicronWhile emerging research suggests the omicron variant may be less likely to lead to severe disease, those who have long Covid say they desperately want to avoid reinfection.
Weiterlesen »